US 8,476,010 B2
Propofol formulations with non-reactive container closures
Log In
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

US 8,476,010 B2
Propofol formulations with non-reactive container closures
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Jon P Weber
Art Unit:
1654 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzyme
Inventors:
Neil P. Desai; Andrew Yang; Sherry Xiaopei Ci
Priority:
07/10/03
Filed:
07/10/03
Granted:
07/02/13
Expiration:
08/04/25
Abstract
A sterile pharmaceutical composition for parenteral administration of propofol, said composition comprising propofol, optionally albumin, and less than about 10% by weight solvent for propofol, wherein said composition is stored in a container having a closure wherein said closure is inert to propofol.
Cooperative Patent Classification (CPC)
A61A61K9/0075A61J1/1468A61K

Analytics

Cases

Patent Assignments

Citations